A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockadeDaniela S. Thommen, Alfred Zippelius|Nature Medicine|2018Cited by 1.2k
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher Garris, Mikaël J. Pittet, Sean P. Arlauckas et al.|Immunity|2018Cited by 937
Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with RapamycinLaura Strauss, Alfred Zippelius|The Journal of Immunology|2007Cited by 330
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Jan P. Böttcher, Thomas Rudolph et al.|Immunity|2023Cited by 176
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapyMarcel P. Trefny, Alfred Zippelius|Nature Communications|2023Cited by 88